Founded in 2023, US RAD Bio are a group of retired professionals from industry, academia, and regulatory authorities in the field of nuclear medicine. Our goal is to assist biotech and pharmaceutical companies on preclinical and clinical development phases, and leverage overseas resources to accelerate drug development via delivery of high quality data.
